Crinecerfont decreases glucocorticoid use in adults with congenital adrenal hyperplasia
1. In this randomized controlled trial, twice daily crinecerfont use was associated with reduced daily glucocorticoid use in adults with ...
Tag: congenital adrenal hyperplasia
Crinecerfont facilitates glucocorticoid dose reduction in pediatric congenital adrenal hyperplasia
1. In this randomized controlled trial of pediatric patients with congenital adrenal hyperplasia (CAH), it was found that treatment with ...
#VisualAbstract: Crinecerfont Improves Outcomes in Pediatric Congenital Adrenal Hyperplasia Patients
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Neonatal screening may be effective for salt wasting congenital adrenal hyperplasia
Image: PD 1. Based on Sweden’s nationwide study on congenital adrenal hyperplasia (CAH) screening, investigators were successfully able to identify ...